Methods
The Mexico City Diabetes Study is a prospective, population-based investigation designed to describe the prevalence and incidence of diabetes and cardiovascular risk factors in lowincome urban population from Mexico City. The detailed methodology has been reported elsewhere. [11] Briefly, the sample size included 2282 men and non-pregnant women aged 35 to 64 years who completed a baseline interview and physical examination in [1989] [1990] . Two follow-up visits were carried out in 1994-1996 (n=1773) and in 1998-2000 (n=1764). All evaluations included medical history, physical examination, ECG, and several laboratory tests. Current smoking was defined as at least one cigarette per day in the last year. Physical examination included an anthropometric evaluation with participants wearing lightweight clothing and no shoes. Height was measured using a stadiometer with subjects standing on the floor with the back against a wall; weight was measured using a clinical scale. Body mass index (BMI) was calculated as weight/height 2 in kg/m 2 . Waist circumference (WC) was measured considering the umbilicus as the landmark. Systolic (SBP) and diastolic blood pressure (DBP) were measured 3 times in the right arm of seated subjects (after resting for at least 5 min) using a random zero sphygmomanometer (Hawksley, London). We used the average of the last 2 readings as the BP of the participants. Hypertension was defined as SBP140 mmHg, DBP90 mmHg, or treatment with antihypertensive drugs. In every visit, participants completed a 75-g oral glucose tolerance test. Diabetes was defined according to the World Health Organization criteria with a fasting glucose ≥7mmol/l (126 mg/dl), 2-hour glucose ≥11.1 mmol/l (200 mg/dl), or treatment with oral antidiabetic drugs. [12] Fasting and 2-hour plasma glucose and insulin as well as fasting serum lipids and all other biomarkers were measured using previously reported methods [13] at the research laboratory of the Division of Clinical Epidemiology at the Medicine Department of the University of Texas Health Science Center at San Antonio, USA. Insulin resistance was estimated by the homeostasis model (HOMA-IR) as follows: [fasting insulin (units/ml) X fasting glucose (mmol/l)/22.5]. A resting standard 12-lead ECG was taken with the subject in a supine position at each examination. A standard interpretation of ECGs at a reading center (Wake Forest University, EPICARE Center) was made using the Minnesota Code. [14] Heart rate (HR), QRS duration, R amplitude in AVL lead (R-AVL), S amplitude in V3 lead (SV3), left ventricular hypertrophy (LVH), QT interval, and myocardial infarction, among other variables, were coded. Left ventricular hypertrophy (LVH) was defined as (R-AVL) + (SV3) ≥2600μv in men and ≥2200μv in women. Myocardial infaction was defined according to the following codes: Q-QS pattern with 1.1-1.2.7, Q-QS and T wave pattern 1.2.8-1.3, and wave T pattern with 5.1-5.3. QT interval was measured from the electrocardiogram tracing in lead II and defined as the first deflection of the QRS complex and the end as the point of maximal change in the slope as the T wave merges with the baseline. QT corrected (QTc) was calculated according to Bazzett's formula as QT/square root of (R-R interval). The same measurement instruments were used throughout the study. The Institutional Review Boards of both The University of Texas Health Science Center and the Centro de Estudios en Diabetes approved the study protocol. Each participant gave informed consent. For this analysis, we included 1661 subjects, 218 with and 1443 without www.intechopen.com type 2 diabetes, without myocardial infarction at baseline corroborrated by ECG, who were followed-up for a median of time of 4.26 and 3.32 years, respectively.
Statistical analysis
Comparisons of clinical and laboratory features were made according to diabetes status at baseline. Proportions and means (standard deviation [s.d.]) were compared by Pearson Chi 2 and by T student, respectively, while medians (interquartile range [IQR] ) were compared by Wilcoxon test. QTc interval was analyzed as continuous and dichotomous variable. Because of the normal distribution of the QTc interval, all analyses were carried out using the original units. QTc interval prolongation, using the Bazzett´s formula, was defined as an interval ≥430 msec in men and 450 msec in women. Partial Pearson correlation between QTc interval and some risk factors were estimated in diabetic and non-diabetic subjects, separately. To estimate the association between some cardiovascular risk factors and QTc interval prolongation in diabetic and non-diabetic subjects, both together and separately, multiple linear regression for cross-sectional analysis and generalized estimating equations regression models (GEE), with family normal identity link, for longitudinal analysis were carried out. Models were performed with the forward method considering the biological and statistical relevance. Results are given as regression β coefficients and 95% confidence interval (95%CI). P value equal or less than 0.05 was considered significant. All analyses were done with Stata/SE 9.0 (Stata statistical software: Release 9. College Station. Texas: Stata Corporation, 2005).
Results

Characteristics of the sample
A total of 1661 subjects (1443 non-diabetic and 218 diabetic subjects), aged 47.4±8.2 years at baseline were included. Table 1 shows comparisons of some QT interval risk factors between subjects with and without type 2 diabetes. Individuals with diabetes were older and had greater abdominal fat and upper-body fat accumulation, as well as higher BP levels, total cholesterol and fasting and 2-hour glucose levels compared with individuals without diabetes. The percentage of hypertension was higher for subjects with diabetes (27.1%) compared with non-diabetic subjects (13.0%); likewise, the proportion of individuals under antihypertensive medication was slightly greater in the diabetic group. Although the percentage of subjects who were under antihyperlipidemic medication was higher in subjects with diabetes compared with non-diabetic subjects, these differences were not significant. As for diabetic subjects, 136 (62.4%) were prevalent cases whereas 82 (37.6%) were incident cases, with a ratio 1:1.6. Mean of age at diagnosis of diabetes was 46.6 years (s.d. 8.0 years) and median of diabetes duration was 1.8 (IQR 25-75% 0-7.3). Some characteristic on the ECG were compared between diabetic and non-diabetic subjects at baseline and during follow-up and are shown in table 2. The mean of heart rate, QRS duration, and R amplitude in AVL lead were significant higher in diabetic compared with non-diabetic subjects. Mean of QTc by the Bazzet´s formula was significantly higher (p<0.001) in diabetic (414.0 msec) than in non-diabetic (404.3 msec) individuals. The prevalence of longer QTc interval (≥430 msec in men and ≥450 msec in women) was greater in diabetic (10.1%) compared with non-diabetic subjects (4.0%). Prevalence was remarkably higher in both diabetic and non-diabetic men (16 Table 1 . Characteristic of the study population by diabetes status women (6.5% vs. 3.7%, p>0.05). Similar differences were observed on the QTc interval as continuous and dichotomous variable during the follow-up. In addition, after stratifying by hypertension, prevalence of longer QTc interval was significantly higher in both diabetic (13.3%) and non-diabetic subjects (5.2%) with hypertension compared with diabetic (8.9%) and non-diabetic subjects (3.8%) without hypertension. When stratification was made by BMI<25 and BMI≥25, prevalence remained significantly higher in diabetic compared with non-diabetic subjects with normal weight (14% vs. 1.8%, respectively) and with overweigh/obesity (9.1% vs. 4.7%, respectively). Missing values in non-diabetic subjects: S amplitude in V3 lead 1. Bazzett´s formula: QT/square root of (R-R interval). Table 2 . QTc interval segment and other electrocardiographic parameters in subjects with and without type 2 diabetes Figure 1 shows the relation between QTc interval and BMI in subjects with and without type 2 diabetes according to age. The values of QTc interval were slightly greater in subjects with greater BMI in both diabetic and non-diabetic individuals, regardless of age group. A similar trend was observed when BMI was substituted for WC. (Data not shown) As for fasting glucose in diabetic subjects, a slight increment in the QTc interval was observed in subjects with higher levels of fasting glucose, particularly in subjects with levels between 12 mmol/l and 20 mmol/l. (Figure 2 ) For non-diabetic subjects, a modest increment in the QTc interval was observed when 2-hour glucose (≥6 mmol/l) and HOMA-IR (≥10 units) increased (Figure 3 ). 
Cross-sectional analysis
In the whole sample, QTc interval prolongation was significantly associated with age, sex, BMI, and diabetes. For each unit of change on age (year), the QTc interval increased 0.36 msec (95%CI 0.23; 0.49). For each unit of increment on BMI, the QTc interval increased 0.75 msec (95%CI 0.51; 1.00). Women had a greater QTc interval mean than men (difference of 13.36 msec (95%CI 11.36; 15.76). Regarding diabetes, the difference on the QTc interval between diabetic and non-diabetic subjects was 6.33 msec (95%CI 3.24; 9.43). Models stratified by diabetes status were also performed. In diabetic subjects, risk factors significantly associated with QTc interval were sex and BMI, whereas age had a borderline significance. For each unit of increment on BMI, the QTc interval increased 0.72 msec (95%CI 0.07; 1.37 Table 3) .
Longitudinal analysis
When the whole sample was considered, the progression of QTc interval prolongation was significantly associated with age, sex, BMI, hypertension, and diabetes. The QTc interval prolongation increased with age (beta= 0.33, 95%CI 0.24; 0.42) and BMI (beta= 0.73, 95%CI 0.56; 0.90). Women had a greater QTc interval prolongation than men (difference of 11.84 msec, 95%CI 10.09; 13.59), as did diabetic compared with non-diabetic subjects (difference of 6.58 msec, 95%CI 4.02; 9.13). In a model restricted to diabetic subjects, the QTc interval was predicted by sex (beta= 11.18, 95%CI 6.27; 16. Table 4) . Antihypertensive therapy had a negative effect in QTc prolongation. In a multivariate model with diabetes duration equal or greater than 1 year, the increment of QT interval prolongation remained similar for fasting glucose (beta=0.38, 95%CI 0.06; 0.70, p=0.021), whereas a significant increment with diabetes duration was observed (beta=0.42, 95%CI 0.04; 0.80, p=0.032). (Data not shown)
Discussion
The methods used in the Mexico City Diabetes Study meet the accepted international criteria in terms of study protocol, diagnostic algorithms, and particularly electrocardiographic interpretations. [11] The ECGs were interpreted without disclosure of clinical or laboratory data, in a reference center recognized as a gold standard for this procedure. A rigorous quality control procedure was followed along the study. In this population, there is a high prevalence of cardiovascular risk factors, namely overweight, Models were run by using generalized estimating equations with family normal and identity link. Table 4 . Risk factors associated with the QT interval prolongation in subjects with and without type 2 diabetes. Longitudinal analysis obesity, diabetes, hypertension, and dyslipidemia. [15] [16] [17] This circumstance offers a unique opportunity to study the effect of the above-mentioned factors on the QTc interval as a proxy for the repercussions of the electrophysiologic phenomena on the heart cycle. Our findings clearly show the deleterious effects of the identified cardiovascular risk factors on the QTc interval, particularly those related to insulin resistance. In the present study, prevalence of QTc interval prolongation was higher in diabetic that in non-diabetic subjects without previous myocardial infarction detected by ECG, independently of age and sex. As expected, subjects with diabetes had 6 times the risk of developing QTc interval prolongation compared with non-diabetic subjects. In multivariate models, QTc interval prolongation was consistently predicted by sex, BMI, and fasting glucose in diabetic subjects. In non-diabetic subjects, age, sex, BMI, hypertension, HOMA-IR, and antihypertensive medication predicted QTc interval prolongation. In both groups, results were largely unchanged when WC was used in place of BMI, or when 2-hour glucose was included instead of fasting and HOMA-IR in diabetic and non-diabetic subjects, respectively. Several studies have demonstrated that the prevalence of prolonged QTc interval is higher in subjects with type 2 diabetes (26%) than in subjects without. [18] [19] [20] [21] Also, the QTc interval www.intechopen.com prolongation has been associated with a high risk of ischemic heart disease, ventricular fibrillation, and sudden death (range 2 to 5) in several studies, even in subjects with short duration of diabetes. [10] In our study, we observed a significantly higher proportion of prolonged QTc interval in diabetic compared with non-diabetic subjects (10.1% vs. 4.0%).
After adjustment for other risk factors, the mean difference on the QTc interval between diabetic and non-diabetic subjects was 6.33 msec. It has been suggested that this difference relates to the sympathetic activity present in diabetes, which reduces both the ability to regulate heart rate and the heart rate variability. [19, 20] As for diabetes duration, it has been reported as a risk factor for chronic complications, including QTc interval prolongation, the latter being related to neuropathy in subjects with diabetes. [19] In our study, neither at baseline nor at follow-up duration of diabetes was significantly associated with QTc interval, which could be explained, in part, by the high proportion of new cases at baseline (37.6%). When the analysis was restricted to subjects with diabetes duration equal or greater than 1 year, QTc interval prolongation was predicted by duration, independently of other risk factors, despite the short median duration of the disease in subjects with previous diagnosis of diabetes (median 5.4 years, IQR 2.1-10.6).
We found a significant prospective association between fasting plasma glucose and prolonged QTc interval in diabetic subjects, even after adjustment for other risk factors. Some studies have reported an association between fasting glucose and QTc interval, particularly in individuals in the normal high level or with impaired fasting glucose, after adjustment for diabetes duration, among other risk factors. [21] [22] However, other studies have not found any significant association. [23] As for non-diabetic subjects, we noted an independent association between HOMA-IR and QT-interval prolongation. These results showed an important degree of insulin resistance, maybe related to overweight and obesity in this population, and both predicted QTc interval prolongation. No association was observed with fasting plasma glucose in this group. By contrast, previous studies have reported an association between plasma glucose and QT interval in healthy subjects [24] , even after hyperglycemic clamp insulin release, which suggests that the effect of glucose on the QTc interval is not mediated by insulin. The association of higher BMI with the prolongation of the QTc interval observed in the non-diabetic group is not clearly seen in the diabetic group, probably because of the effect of weight loss as a result of poor metabolic control. It is particularly interesting the finding that HOMA-IR index has a significant association with the prolongation of the QTc duration in both the cross-sectional and the prospective analyses. The pathophysiologic implications direct our attention to the cellular effects of insulin resistance in the electrophysiology that mediates the depolarization and repolarization of the myocardium. Somewhat surprisingly, we could not show a demonstrable effect of therapy for diabetes or hypertension in the QTc duration. Some of the limitations with the QT interval evaluation relate to the lack of accuracy and reproducibility of the measurements, since there is no standard method for analysis and lead selection. The definition for the end of the QT interval is unclear as well, and may represent a changing T wave morphology that could provide a measure of altered disparity of repolarization. [25, 26] Nevertheless, its application as a non-invasive and cost-effective screening tool is invaluable for cardiovascular risk stratification of population. On the other hand, because of the lack of QT interval dispersion measurement in this study, we were not able to determine the type of variation on repolarization.
Conclusion
In this study, in addition to specific cardiovascular risk factors associated with the QTc interval prolongation in diabetic and non-diabetic subjects, general excess of body weight measured by BMI was a significant risk factor for both groups. Our findings clearly show the deleterious effects of the identified cardiovascular risk factors on the QTc interval, particularly those related to insulin resistance. In diabetic subjects, the lack of metabolic control (measured by fasting glucose level) predicted strongly the QTc prolongation, whereas in non-diabetic subjects the presence of insulin resistance (HOMA-IR) predicted it. Given the cardiovascular clinical implications of QTc interval in subjects with and without diabetes, further interventional researches are needed to confirm whether the metabolic control in diabetic subjects and the decrease of insulin resistance in non-diabetic subjects together with weight reduction can prevent QTc interval prolongation.
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